Chronic cough drug developer plays it cool as it seeks cash for late-stage study


Can the "ice cream receptor" reduce chronic cough? A small Peninsula company thinks so, if it can get enough money to pay for a late-stage clinical trial.

Previous These 25 Portland-area public companies grew most during the pandemic
Next A new luxury independent living development is close to market amid increasing demand